Skip to main content

Field Guide

Top Clinical Medicine Journals

Top journals for clinical research, trials, and medical practice. This guide covers 25 journals with impact factors, acceptance rates, review timelines, and open access costs - everything you need to choose the right venue for your research.

25
Journals Covered
6
Elite / Top Tier
14
Strong Options
5
More Accessible

Journal Comparison Table

JournalTierImpact FactorAcceptance RateReview TimeOpen Access
The Lancet
Lancet
Top Tier109about 5%Not published by the journalSee details
New England Journal of Medicine
NEJM
Top Tier84.5<5%Not published by the journalSee details
JAMA (Journal of the American Medical Association)
JAMA
Top Tier65.410% of submissions; 4% of research manuscripts24 days with review; 2 days without review (medians)See details
Nature MedicineTop Tier52.3Not published by the journal4 days median to first decision (2025)See details
GastroenterologyTop Tier29.714%~25 daysSee details
GutTop Tier24.612%23 days with review; 3 days without review (medians, 2025)See details
The BMJ (British Medical Journal)
BMJ
Strong Option55.1Not published by the journalNot published by the journalSee details
Lancet Infectious DiseasesStrong Option29.413%2-4 weeks to first decisionSee details
BloodStrong Option23.9Not published by the journal15 days average to first decision (unsolicited submissions)See details
Diabetes CareStrong Option22.611.06%18 days average to first decisionSee details
Trends in Molecular Medicine
Trends Mol. Med.
Strong Option18.137%Not publicly verifiedSee details
HepatologyStrong Option18Not published by the journalNot published by the journalSee details
Science Translational MedicineStrong Option15.64.6% (2025)7 days median to first decision; 82 days after review (2025)See details
DrugsStrong Option14.7Proposal and invitation ledPresubmission inquiry before invited Review developmentSee details
Journal of Clinical Investigation
J. Clin. Investigation
Strong Option14.39.5% (June 2025 to May 2026)35.0 days with review; 5.4 days without review (averages, June 2025 to May 2026)See details
JAMA Network OpenStrong Option11.712%46 days with review; 2 days without review (medians)See details
PhytomedicineStrong Option11.313%~4-8 weeksSee details
DiabetologiaStrong Option10.4<15%Not published by the journalSee details
Clinical Infectious Diseases
Clin. Infect. Dis.
Strong Option8.3Not published by the journal6 days to first decision; 39 days excluding desk rejectionsSee details
Biomedicine & PharmacotherapyStrong Option7.516%Editorial screening first; peer review after editor fitSee details
PLOS MedicineAccessible9.94% (2025)67 days median to first decision (2025)See details
BMC MedicineAccessible8.7Not published by the journal3 days median to first editorial decisionSee details
Frontiers in Pharmacology
Front. Pharmacol.
Accessible5.4Not officially publishedVaries by specialty section and review pathSee details
PLOS PathogensAccessible4.922%22 days to first decisionSee details
BMJ OpenAccessible2.527%134 days median with reviewSee details

Found your target journal - now check if your manuscript is ready

Most desk rejections come down to scope and framing, not the science itself. Start with the Free Readiness Scan to check your manuscript against what clinical medicine editors actually look for before you commit to a submission.

Start with the Free Readiness Scan. Unlock the Full Review from $39, with local pricing shown before checkout. If you need deeper submission planning, choose the Submission-Ready Dossier.

Private API processing. Your manuscript is not used to train models.

Run my Free Readiness Scan →

Understanding Journal Tiers

Top Tier

Tier 1 (NEJM, Lancet, Nature Medicine, JAMA): For practice-changing clinical trials, novel mechanistic insights with therapeutic implications, or major cohort studies. Expect 3-6 months to first decision, 60-80% desk rejection rate. Your cover letter must immediately articulate clinical significance.

Strong Option

Tier 2 (BMJ): For well-designed clinical studies, systematic reviews, and health policy analyses. More accessible than Tier 1 but still selective. BMJ particularly values work with clear implications for clinical practice guidelines.

Accessible

Tier 3 (PLOS Medicine, BMJ Open): More inclusive peer review, higher acceptance rates. Appropriate for solid clinical research that doesn't meet Tier 1/2 novelty thresholds. BMJ Open publishes across clinical medicine and is fully open access.

Publishing in Clinical Medicine

Clinical medicine journals sit at the top of the academic publishing pyramid. The top five - NEJM, Lancet, Nature Medicine, JAMA, and BMJ - collectively reject over 95% of submissions. But there's a realistic path through the stack depending on your data quality and career stage. NEJM and Lancet are the giants. Both publish practice-changing clinical trials and major cohort studies. If your work reshapes how doctors treat patients, these are your targets. The catch: they receive thousands of submissions and desk-reject most without review. Your cover letter needs to immediately signal why your findings matter to clinical practice. Nature Medicine sits between basic and clinical. They want mechanistic insights with clear therapeutic implications - not just another cohort study. If your work explains *why* a treatment works at the molecular level in humans, this is your venue. JAMA and BMJ are more accessible while maintaining rigor. JAMA has a strong US focus and faster timelines than the giants. BMJ is more global in scope and more willing to publish systematic reviews and policy-relevant work. For most clinical researchers, BMJ or PLOS Medicine is the realistic starting point. These journals maintain high standards but have substantially higher acceptance rates than the elite tier. Your goal should be establishing credibility at this level before aiming higher.

Guidance by Career Stage

🎓 Graduate Students

As a grad student, BMJ Open or PLOS Medicine is your realistic entry point. Target these journals first to establish a publication record. Your advisor should be middle author on any Tier 1 submission - the senior name carries weight with editors.

🔬 Postdocs

If you have a strong clinical dataset - particularly from a well-known cohort or trial - BMJ or JAMA becomes realistic. Postdocs with practice-changing data can aim for Tier 1 if the senior author (your PI) takes corresponding authorship. Never submit to NEJM/Lancet as first author without PI endorsement.

👨‍🔬 Principal Investigators

As a PI, the calculus changes. You can leverage your publication record to get past desk review at Tier 1 journals. Consider whether your goal is speed (JAMA ~3-4 months to decision) or impact (NEJM/Lancet 6+ months but broader reach). Many PIs now skip the giants for career advancement and publish in their specialty journals instead.

⏱️ Review Timelines

NEJM and Lancet: 6-12 weeks to initial decision after peer review. First decision typically 2-4 weeks for desk-rejected manuscripts. JAMA: faster, typically 3-8 weeks to first decision. BMJ: 4-8 weeks to initial decision. PLOS Medicine: 2-4 months.

🔓 Open Access & Costs

NEJM, Lancet, and JAMA are subscription journals with optional open access (~$3,000-5,000). Nature Medicine offers open access for $11,690. BMJ and PLOS Medicine are fully open access - PLOS Medicine charges $3,500, BMJ Open is free to publish (Gold open access).

Common Mistakes to Avoid

  • ✕Submitting observational studies to NEJM without exceptionally large sample size or novel findings
  • ✕Not clearly stating clinical implications in the cover letter
  • ✕Skipping the 'clinical significance' question editors ask first
  • ✕Not checking journal scope - NEJM specifically states they want 'practice-changing' research

Frequently Asked Questions

Which clinical medicine journal has the highest impact factor?

NEJM has the highest IF at 78.5, followed by Lancet (88.5) - though Lancet's IF is boosted by the COVID-19 pandemic. For clinical relevance rather than raw citations, NEJM and Lancet are considered peers.

What's the fastest clinical medicine journal?

BMJ Open and PLOS Medicine typically offer the fastest timelines at 2-4 months to first decision. JAMA averages 3-8 weeks. The elite journals (NEJM, Lancet) can take 6+ months for accepted papers but often desk-reject within 2-4 weeks.

Do I need a clinical trial to publish in NEJM?

No, but NEJM primarily publishes clinical trials, large cohort studies, and systematic reviews. Basic science, even if medically relevant, typically goes to Nature Medicine or a specialty journal.

Latest Journal-Specific Guides in This Field

More Guides in This Field

Clin. Infect. Dis. • Desk rejection
How to Avoid Desk Rejection at Clinical Infectious Diseases
How to avoid desk rejection at Clinical Infectious Diseases: what editors screen for and how to make the clinical consequence obvious.
Journal • Desk rejection
How to Avoid Desk Rejection at JCI Insight (2026)
Avoid desk rejection at JCI Insight with stronger field advance, broader physician-scientist relevance, and cleaner translational logic.
Nature Medicine • Publishing guide
How to Get Published in Nature Medicine (2026)
Nature Medicine publishes no acceptance rate. What the editors need to see before they send a paper out to review.
Journal • Submission guide
Metabolism Submission Guide
A practical Metabolism submission guide for metabolic researchers evaluating their work against the journal's clinical and translational bar.
Nature Medicine • Acceptance rate
Nature Medicine Acceptance Rate 2026: How Selective Is It?
What Nature Medicine's selectivity means for a bench-to-bedside paper, how editors screen at the desk, and who gets published.
Nature Medicine • Submission guide
Nature Medicine Submission Guide: What to Prepare Before You Submit
A practical Nature Medicine submission guide for authors deciding whether the manuscript is translationally strong enough, clinically relevant enough, and complete enough for the journal.
Phytomedicine • Submission guide
Phytomedicine Submission Guide
A practical Phytomedicine submission guide for natural-product pharmacology researchers evaluating their work against the journal's mechanism and translational bar.
PLOS Medicine • Review timeline
PLOS Medicine Review Time: What Authors Can Actually Expect
PLOS Medicine is a journal where the first useful timing question is whether the editors think the paper matters beyond one health system, not just how quickly reviewers reply.
PLOS Medicine • Submission guide
PLOS Medicine Submission Guide: What to Prepare Before You Submit
A practical PLOS Medicine submission guide covering the initial submission process, global health framing, reporting requirements, and what must be true before your paper enters review.
PLOS Medicine • Submission process
PLOS Medicine Submission Process: What Happens After Your Initial Submission
A practical PLOS Medicine submission process guide covering the two-stage submission workflow, editorial screening, peer review stages, and what each decision means.
Biomedicine & Pharmacotherapy • Submission guide
Biomedicine and Pharmacotherapy Submission Guide
A practical Biomedicine and Pharmacotherapy submission guide for biomedical researchers evaluating their work against the journal's pharmacotherapy bar.
Biomedicine & Pharmacotherapy • Submission process
Biomedicine and Pharmacotherapy Submission Process: What Happens After Upload
A practical Biomedicine & Pharmacotherapy submission process guide covering Editorial Manager upload, PDF approval, technical checks, editor triage, review-proposal handling, peer review, and decisions.

Ready to submit? Check your manuscript first.

Start with the Free Readiness Scan to review your scope, significance framing, methods, and literature coverage against clinical medicine journal standards before you submit.

Start with the Free Readiness Scan. Unlock the Full Review from $39, with local pricing shown before checkout. If you need deeper submission planning, choose the Submission-Ready Dossier.

Private API processing. Your manuscript is not used to train models.

Run my Free Readiness Scan →